antineoplaston a10 has been researched along with Urinary Bladder Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arihiro, K; Hanamoto, M; Hayashi, T; Hinata, N; Ikeda, K; Ishida, K; Kaneko, Y; Kobayashi, G; Nobuhiro, R; Nose, H; Oue, N; Saito, Y; Sentani, K; Shibata, J; Uraoka, N | 1 |
1 other study(ies) available for antineoplaston a10 and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Dual immunocytochemical staining of annexin A10 and p53 in low-grade and papillary urothelial carcinoma contributes to improvement of diagnostic accuracy in urine cytology.
Topics: Annexins; Carcinoma, Transitional Cell; Humans; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Urine | 2023 |